This solicitation by the Centers for Disease Control and Prevention (CDC) seeks quotes for a maintenance service contract for Illumina NovaSeq 6000 and MiSeq sequencing instruments, with a performance period from December 7, 2024, to December 6, 2025. The contract, categorized under NAICS code 811219, is structured as a firm-fixed-price purchase. It outlines requirements for repair and maintenance services, emphasizing the need for manufacturer-approved parts, prompt on-site repair responses within two business days, and annual preventive maintenance. The CDC's Genomic Sequencing Laboratory (GSL) plays a vital role in sequencing for various programs, necessitating high-quality maintenance services to manage a high volume of samples, particularly from disease outbreaks. Offerors must adhere to applicable Federal Acquisition Regulation (FAR) provisions and be registered in the System for Award Management (SAM). Interested parties are to submit their proposals to a designated CDC official by October 21, 2024. The document highlights compliance, regulatory clauses, deliverables, and communication protocols, ensuring that contractor personnel maintain clear identification as non-government employees during all interactions.
The document outlines the justification for a sole source procurement by the Centers for Disease Control and Prevention (CDC) for maintenance, repair, and support of the Illumina NovaSeq 6000 and MiSeq instruments, estimated at $144,910.12. The procurement must follow FAR regulations, specifically FAR 13.106-1(b) and FAR 8.405-6, which permit acquisitions from a single source under compelling circumstances. The justification includes the necessity for compatibility and continuity of support for instruments critical during public health emergencies.
Direct support from the manufacturer is emphasized as essential due to the urgency of repairs and the rapid response required for outbreak studies, while third-party services are deemed insufficient due to longer timelines and procedural delays. The program office, represented by Faye Rashid, certifies that the justification is accurate and necessary for non-competitive action. The contracting officer must also validate this justification for it to proceed, ensuring that federal regulations for sole source procurement are adhered to, thereby underscoring the efficiency of operations within the CDC during public health crises.